|
|
Volumn 12, Issue 10, 2001, Pages 1407-1410
|
|
A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma
a
|
|
Author keywords
Advanced oesophageal and gastric adenocarcinoma; Phase II; Tomudex
|
|
Indexed keywords
CISPLATIN;
EPIRUBICIN;
RALTITREXED;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CARDIOPULMONARY INSUFFICIENCY;
CAUSE OF DEATH;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOLOGY;
DIARRHEA;
DISEASE CLASSIFICATION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG RESPONSE;
DRUG WITHDRAWAL;
ENTERITIS;
ESOPHAGUS CARCINOMA;
FEMALE;
HEART DISEASE;
HISTOPATHOLOGY;
HUMAN;
INOPERABLE CANCER;
KIDNEY FUNCTION;
LIVER FUNCTION;
LUNG EMBOLISM;
MALE;
MEDICAL DECISION MAKING;
METASTASIS;
NAUSEA;
NEUTROPENIA;
PERFORMANCE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SEPSIS;
STATISTICAL ANALYSIS;
STOMACH ADENOCARCINOMA;
VOMITING;
|
|
EID: 0035189069
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1012552823543 Document Type: Article |
|
Times cited : (21)
|
|
References (12)
|
